Yangzhou Huitong Technology Corp.,
301601
Scantech
688583
KAISA JiaYun Technology Inc.
300242
Fuchun Technology
300299
Hangzhou Onechance Tech Corp.
300792
CN Stock MarketDetailed Quotes
600572 Zhejiang Conba Pharmaceutical
- 4.38
- -0.05-1.13%
Market Closed Jan 15 15:00 CST
11.31BMarket Cap23.30P/E (TTM)
4.42High4.36Low198.01KlotVolume4.40Open4.43Pre Close86.71MTurnover0.77%Turnover Ratio19.13P/E (Static)2.58BShares5.5452wk High1.69P/B11.28BFloat Cap3.8752wk Low4.87Limit Up2.58BShs Float12.13Historical High3.99Limit Down1.35%Amplitude-0.82Historical Low0.20Dividend TTM4.38Avg Price118.56KlotAsk4.57%Div YieldTTM100Lot Size73.16KlotBid
Zhejiang Conba Pharmaceutical News
Conn Bay: Announcement on Audit Institution Changes Project Quality Control Reviewers
Conn Bay: Announcement on the company\'s president adjustments
Kangenbei: Announcement of Resolutions of the Fifth (Interim) Meeting of the 11th Board of Directors of the Company
Announcement of Resolutions of the Fifth (Provisional) Meeting of the 11th Board of Directors of the Company
Kangenbei: Announcement on the company\'s drug passing the generic drug consistency evaluation
Announcement on the company\'s drug passing the generic drug consistency evaluation
Announcement on the holding of the 2024 three-quarter report results briefing
Connbey: Announcement on holding the 2024 three-quarter report results briefing
Conn Bay: Resolutions of the 1st Meeting of the 11th Board of Directors Remuneration and Assessment Committee in 2024
Conn Bay: Announcement of Resolutions of the Fourth (Interim) Meeting of the 11th Board of Supervisors of the Company
Kangenbei: Announcement of Resolutions of the Fourth (Interim) Meeting of the 11th Board of Directors of the Company
Announcement of Resolutions of the Fourth (Interim) Meeting of the 11th Board of Directors of the Company
Announcement on holding the 2024 three-quarter report results briefing
Resolutions of the 1st Meeting of the 11th Board of Directors Remuneration and Assessment Committee in 2024
Announcement of Resolutions of the Fourth (Interim) Meeting of the 11th Board of Supervisors of the Company
Company announcement on ZY13 extract and its tablets obtaining approval notice for drug clinical trials
Announcement on the holding of the 2024 semi-annual results briefing
Announcement on holding the 2024 semi-annual results briefing and question collection
Minutes of Institutional Investor Research Activities (2024.8)
Announcement regarding the company's primary business data for the first half of 2024.
